Plan

CREATING HOPE FOR ALL FACING ILLNESS

MISSION:  Our MISSION is to create treatment choices that bring new hope, both for those who are facing illness today and those who may face illness in the future.

BE A HEALTHCARE COMPANY THAT DELIVERS OPTIMAL THERAPY TO EACH INDIVIDUAL

VISION 30:  When considering our MISSION, we decided that by 2030 healthcare will expand beyond hospitals and into private homes and will require total care that encompasses daily activities and emphasizes the satisfaction of patients and their families. Under VISION 30, our company will provide therapeutic agents and wide-ranging solutions designed with the patient and their family in mind. We see three key areas where we will continue to provide value:

  • •  Provide highly effective treatments to specific patient groups and increase patient satisfaction with detailed analysis of the disease
  • •  Provide solutions focused on prevention, pre-symptomatic disease care, prevention of aggravation and prognosis.
  • •  Continue improving the value of our therapeutics and solutions by collecting and analyzing healthcare data.

Our Medium-Term Management Plan 21–25 covers the first five years in our efforts to achieve VISION 30

      • Research & Development

        Develop precision medicine focused on central nervous system and immune-inflammation treatments.

      • Focus on vaccines and contribute to preventive medicine

      • Business Development

        Strengthen business in the U.S. and Japan, developed “around the pill” solutions to create new customer contact points

      • Management Base

        Create a resilient organization and optimize the allocation of management resources for achieving VISION 30

    Click here for more details on our Medium-Term Management Plan 21–25